Protein kinase Cε and protein kinase Cθ double-deficient mice have a bleeding diathesis

A J Unsworth1, B A Finney, L Navarro-Nunez

  • 1Department of Biochemistry, University of Oxford, UK.

Abstract

Insights

Novel protein kinase C (PKC) isoforms, PKCθ and PKCε, play a greater than additive role in supporting platelet activation under shear conditions. Combined deficiency significantly increases tail bleeding and reduces platelet aggregation.

Area of Science:

  • Hematology
  • Molecular Biology
  • Biochemistry

Background:

  • Classical protein kinase C (PKC) isoforms are well-studied in platelet regulation.
  • Novel PKC isoforms (PKCθ and PKCε) were previously thought to have minor or inhibitory roles in platelet activation and thrombosis.

Purpose of the Study:

  • To quantify PKCθ and PKCε levels in platelets.
  • To investigate the functional consequences of combined PKCθ and PKCε deficiency in mice.

Main Methods:

  • Assessed tail bleeding times in wild-type and knockout mice.
  • Performed platelet aggregation and activation assays.
  • Studied platelet adhesion and spreading on fibrinogen.

Main Results:

  • PKCε minimally supports GPVI-stimulated aggregation and secretion but not spreading.
  • PKCθ minimally supports fibrinogen adhesion and filopodial generation but not GPVI-induced aggregation.
  • Combined PKCθ and PKCε deficiency markedly reduces collagen-induced platelet aggregation under shear stress.
  • Double-deficient mice exhibit significantly increased tail bleeding times.

Conclusions:

  • PKCθ and PKCε have a synergistic role in platelet activation under shear conditions.
  • The combined absence of PKCθ and PKCε significantly impairs platelet function and hemostasis.

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Cytoskeletal Linker Proteins - Plakins01:09

Cytoskeletal Linker Proteins - Plakins

Plakins are large proteins with binding domains for microtubules, microfilaments, intermediate filaments, and membrane-associated protein complexes at cell junctions. Plakin functions are evolutionarily conserved and are primarily involved in organizing the different components of the cytoskeleton by crosslinking them to each other and connecting them to the cell-matrix and cell adhesion complexes. They are also known to interact with signal transducers, serve as scaffolds for signaling...